Fabomotyzol | Afobazole tablets 10 mg, 60 pcs.

Packing

60 tablets.

Pharmacological action of

Afobazole is a derivative of 2-mercaptobenzimidazole, a selective anxiolytic not belonging to the class of benzodiazepine receptor agonists. Prevents the development of membrane-dependent changes in the GABA receptor.

The drug has an anxiolytic effect with an activating component that is not accompanied by hypnotic effects (sedative effects are detected in doses 40-50 times higher than the ED50 for anxiolytic effects). The drug has no muscle relaxant properties, a negative effect on memory and attention.

When using the drug, drug dependence does not form and withdrawal syndrome does not develop. The action of the drug is implemented mainly in the form of a combination of anxiolytic (anti-anxiety) and easily stimulating (activating) effects.

Reduction or elimination of anxiety (preoccupation, bad feelings, apprehension, irritability), tension (timidity, tearfulness, anxiety, inability to relax, insomnia, fear), and therefore somatic (muscle, sensory, cardiovascular, respiratory, gastrointestinal intestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty concentrating, impaired memory) disorders are observed on days 5-7 of treatment with Afobazole.

Indications

Anxiety in adults:

generalized anxiety disorders, neurasthenia,

adaptation disorders in patients with various somatic (bronchial asthma, irritable bowel syndrome, SLE, coronary heart disease, arterial hypertension, arrhythmias and other diseases sleep-related anxiety

neurocirculatory dystonia

premenstrual tension syndrome

alcohol withdrawal syndrome

to alleviate withdrawal symptoms in case of failure smoking.

Contraindications

pregnancy

lactation (breastfeeding)

age under 18

hypersensitivity to Afobazole components.

Use during pregnancy and lactation

The drug is contraindicated in pregnancy and lactation (breastfeeding).

Composition

1 tablet contains

morpholinoethylthioethoxybenzimidazole dihydrochloride 10 mg

excipients:

potato starch,

microcrystalline cellulose,

lactose,

lactose, srdl

magnesium stearate.

Side effects

Allergic reactions possible.

Rarely - a headache that usually goes away on its own and does not require discontinuation of the drug.

Overdose

Symptoms: With a significant overdose and intoxication, the development of a sedative effect and increased drowsiness without manifestations of muscle relaxation.

Treatment: as a first aid appoint p / to caffeine-benzoate of sodium 20% solution on 1 ml 2-3 times / days.

Storage conditions

The drug should be stored out of the reach of children, in a dry, dark place at a temperature of no higher than 25 РC.

Expiration

2 years.

Deystvuyuschee substances

Fabomotyzol

Terms of delivery from pharmacies

Over-the-counter

dosage form well

Dosage form

tablets

Pharmstandard-Leksredstva, Russia